Oaktree Acquisition Corp III Life Sciences
OACC
48 hedge funds and large institutions have $175M invested in Oaktree Acquisition Corp III Life Sciences in 2025 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 9 reducing their positions, and 4 closing their positions.
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
11% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 9
2% more funds holding
Funds holding: 47 → 48 (+1)
1.01% more ownership
Funds ownership: 83.31% → 84.32% (+1%)
2% more capital invested
Capital invested by funds: $172M → $175M (+$2.63M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ECP
Empyrean Capital Partners
Los Angeles,
California
|
+$7.84M |
| 2 |
MC
Meteora Capital
Boca Raton,
Florida
|
+$2.08M |
| 3 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$1.87M |
| 4 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$1.63M |
| 5 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
+$1.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LIP
Lighthouse Investment Partners
Palm Beach Gardens,
Florida
|
-$8.88M |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
-$4.49M |
| 3 |
JP Morgan Chase
New York
|
-$1.31M |
| 4 |
MSU
Mizuho Securities USA
New York
|
-$940K |
| 5 |
VF
Virtu Financial
New York
|
-$493K |
OACC Hedge Fund Activity: Q3 2025 in Review
48 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Oaktree Acquisition Corp III Life Sciences (OACC) for Q3 2025, worth a combined $175M — up 1.5% from $172M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new OACC positions and 4 closed out — a net gain of 1 holder — while 10 added to existing stakes and 9 trimmed.
The largest buyer was Empyrean Capital Partners, opening a new position worth an estimated $7.84M. The largest seller was Lighthouse Investment Partners, exiting entirely with an estimated $8.88M sold.
- 48 institutional investors held Oaktree Acquisition Corp III Life Sciences (OACC) as of Q3 2025, up from 47 in Q2 2025.
- Funds reported $175M of Oaktree Acquisition Corp III Life Sciences stock for Q3 2025, up 1.5% quarter-over-quarter.
- 5 funds opened new Oaktree Acquisition Corp III Life Sciences positions in Q3 2025 and 4 closed out, a net change of +1 holder.
- The largest Oaktree Acquisition Corp III Life Sciences buyer in Q3 2025 was Empyrean Capital Partners, an estimated $7.84M added.
- The largest Oaktree Acquisition Corp III Life Sciences seller in Q3 2025 was Lighthouse Investment Partners, an estimated $8.88M sold.
Based on aggregated 13F filings for Q3 2025.